Search by Drug Name or NDC
NDC 68382-0536-01 Potassium Citrate 5 meq/1 Details
Potassium Citrate 5 meq/1
Potassium Citrate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is POTASSIUM CITRATE.
MedlinePlus Drug Summary
Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney disease and gastrointestinal disease with vomiting and diarrhea) and drugs, especially diuretics ('water pills'), remove potassium from the body. Potassium supplements are taken to replace potassium losses and prevent potassium deficiency. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 68382-0536-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Potassium
Product Information
| NDC | 68382-0536 |
|---|---|
| Product ID | 68382-536_b0382b88-fcc4-44de-b66d-a93dabc596f8 |
| Associated GPIs | 56202010200420 |
| GCN Sequence Number | 008250 |
| GCN Sequence Number Description | potassium citrate TABLET ER 5 MEQ ORAL |
| HIC3 | R1S |
| HIC3 Description | URINARY PH MODIFIERS |
| GCN | 14950 |
| HICL Sequence Number | 000548 |
| HICL Sequence Number Description | POTASSIUM CITRATE |
| Brand/Generic | Generic |
| Proprietary Name | Potassium Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Potassium Citrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | meq/1 |
| Substance Name | POTASSIUM CITRATE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203546 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0536-01 (68382053601)
| NDC Package Code | 68382-536-01 |
|---|---|
| Billing NDC | 68382053601 |
| Package | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-536-01) |
| Marketing Start Date | 2014-08-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.1909 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | POTASSIUM CITRATE ER 5 MEQ TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |